In 1931 the Spanish immigrant Mr. Gerardo Ramón Cerdá settled in Montevideo and initiated production, starting by nutritional supplements and progressively adding medical specialties. The company grew and from 1956 it turned into Gerardo Ramon y Cia S.A. setting up its first own premises at Joaquin Suarez No. 3359 street.
In 1992 Laboratorios Bagó of Argentina, founded in 1934 by Mr. Sebastián Bagó, a Spanish immigrant, joined Gerardo Ramon y Cia. thus becoming Gramón Bagó de Uruguay S.A. (Gramón Bagó).
The synergy resulting from the merger of both lines (Gramón and Bagó) positions us until today, among the leading companies in the Uruguayan pharmaceutical market.
We have been incorporating representation of well-known prestigious pharmaceutical companies, as detailed in order of association: Dr. Falk Pharma GmbH, Química Montpellier S.A., IBSA -Institut Biochimique S.A., Bioprofarma S.A., Hospira Inc., Galderma S.A., Becton Dickinson - BD Diabetes Care, Meda Pharma GmbH Co. KG, Oystershell NV, NutraPharm S.A., Mead Johnson Nutrition, biose.
We have launched unique and innovative products that are nowadays leaders in their segments like Dirox, Condroxamín, Dioxaflex, Bio Grip, Myelenz, and have brought about great improvement in treatments and patient's quality of life.
In addition to our broad range of general therapeutic products that benefit the entire population, we are working hard on incorporating more specific treatments for diseases affecting small populations such as multiple sclerosis , rheumatoid arthritis, Parkinson disease, leukaemia , among others. Based on research and technology we are committed to make available new therapies to patients and medical staff so as more people access to the best medicines that give them a better quality of life.
We have our own production plant and quality control laboratory, certified by GMP (Good Manufacturing Practices).
Such certification was granted by Health Authority - Health Ministry -following directives of the World Health Organization (WHO). It is the document that first world countries require to import our products.